title: DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes.
abstract: The tumor suppressor p53 and its close relative p73 are activated in response to DNA damage resulting in either cell cycle arrest or apoptosis. Here, we show that DNA damage induces the acetylation of p73 by the acetyltransferase p300. Inhibiting the enzymatic activity of p300 hampers apoptosis in a p53(-/-) background. Furthermore, a nonacetylatable p73 is defective in activating transcription of the proapoptotic p53AIP1 gene but retains an intact ability to regulate other targets such as p21. Finally, p300-mediated acetylation of p73 requires the protooncogene c-abl. Our results suggest that DNA damage-induced acetylation potentiates the apoptotic function of p73 by enhancing the ability of p73 to selectively activate the transcription of proapoptotic target genes.
authors.affiliation: Laboratory of Gene Expression, Fondazione Andrea Cesalpino, University of Rome La Sapienza, 00161, Rome, Italy.
authors.forename: Antonio
authors.initials: A
authors.lastname: Costanzo
authors.forename: Paola
authors.initials: P
authors.lastname: Merlo
authors.forename: Natalia
authors.initials: N
authors.lastname: Pediconi
authors.forename: Marcella
authors.initials: M
authors.lastname: Fulco
authors.forename: Vittorio
authors.initials: V
authors.lastname: Sartorelli
authors.forename: Philip A
authors.initials: PA
authors.lastname: Cole
authors.forename: Giulia
authors.initials: G
authors.lastname: Fontemaggi
authors.forename: Maurizio
authors.initials: M
authors.lastname: Fanciulli
authors.forename: Louis
authors.initials: L
authors.lastname: Schiltz
authors.forename: Giovanni
authors.initials: G
authors.lastname: Blandino
authors.forename: Clara
authors.initials: C
authors.lastname: Balsano
authors.forename: Massimo
authors.initials: M
authors.lastname: Levrero
mesh_terms: D000107:Acetylation; D017209:Apoptosis / Q000235:genetics*; D051017:Apoptosis Regulatory Proteins; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins / Q000235:genetics / Q000378:metabolism; D004249:DNA Damage; D004268:DNA-Binding Proteins / Q000235:genetics* / Q000378:metabolism; D005786:Gene Expression Regulation; D016147:Genes, Tumor Suppressor; D006801:Humans; D009687:Nuclear Proteins / Q000235:genetics* / Q000378:metabolism; D011506:Proteins / Q000235:genetics / Q000378:metabolism; D014407:Tumor Cells, Cultured; D000072160:Tumor Protein p73; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000378:metabolism; D025521:Tumor Suppressor Proteins
chemical_list: D051017:Apoptosis Regulatory Proteins; C493956:CDKN1A protein, human; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins; D004268:DNA-Binding Proteins; D009687:Nuclear Proteins; C414742:P53AIP1 protein, human; D011506:Proteins; C000606460:TP73 protein, human; D000072160:Tumor Protein p73; D016159:Tumor Suppressor Protein p53; D025521:Tumor Suppressor Proteins